India's Lupin Recalls Antibiotic in U.S.
Mumbai-based drugmaker Lupin is recalling ten thousand bottles of its Suprax antibacterial drugs after finding that they failed to meet U.S. standards for impurities.
More Antitrust Probes for Novartis, Roche
France's competition authority is investigating Swiss drugmakers Roche and Novartis on suspicion they were involved in anti-competitive practices in relation to the distribution of their eye disease treatments.
Takeda, Lilly Fined $9B for Hiding Cancer Risks
A Louisiana federal court ordered Takeda Pharmaceutical Co. and Eli Lilly & Co. to pay a combined $9 billion in punitive damages after a jury found they covered up the cancer risks of their Actos diabetes drug.
FDA Shames GSK for Contaminated APIs at Ireland Plant
The U.S. FDA issued a warning letter to GlaxoSmithKline after determining that GSK did not take sufficient action to resolve problems after contaminated APIs were found at the drugmaker's Ireland manufacturing plant.